C N Chesterman

977 total citations
32 papers, 775 citations indexed

About

C N Chesterman is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, C N Chesterman has authored 32 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in C N Chesterman's work include Platelet Disorders and Treatments (11 papers), Blood properties and coagulation (8 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). C N Chesterman is often cited by papers focused on Platelet Disorders and Treatments (11 papers), Blood properties and coagulation (8 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). C N Chesterman collaborates with scholars based in Australia, India and South Korea. C N Chesterman's co-authors include Steven A. Krilis, H. Patrick McNeil, Francis J. Morgan, Beng H. Chong, T. John Martin, Wendy Hope, MC Berndt, Michael C. Berndt, Timothy Brighton and Philip J. Hogg and has published in prestigious journals such as Nature, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

C N Chesterman

31 papers receiving 722 citations

Peers

Countries citing papers authored by C N Chesterman

Since Specialization

Citations

This map shows the geographic impact of C N Chesterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C N Chesterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C N Chesterman more than expected).

Fields of papers citing papers by C N Chesterman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C N Chesterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C N Chesterman. The network helps show where C N Chesterman may publish in the future.

Co-authorship network of co-authors of C N Chesterman

This figure shows the co-authorship network connecting the top 25 collaborators of C N Chesterman. A scholar is included among the top collaborators of C N Chesterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C N Chesterman. C N Chesterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of IgG Fc receptors on CD34 antigen‐expressing cell lines (KG‐1 and KG‐la) 1996 ·Immunology and Cell Biology ·Zhanhe Wu, Boban Markovic, C N Chesterman, Beng H. Chong	5
2	Quantitation of soluble and membrane‐bound FC7RIIA (CD32A) mRNA in platelets and megakaryoblastic cell line (Meg‐01) 1995 ·British Journal of Haematology ·Boban Markovic, Zhanhe Wu, C N Chesterman, Beng H. Chong	18
3	Identification of IgG Fc receptor type II on human megakaryoblastic cell lines (MEG‐01 and UT‐7) 1993 ·British Journal of Haematology ·Zhanhe Wu, C N Chesterman, Beng H. Chong	5
4	Topographical Association of the Platelet Fc-receptor with the Glycoprotein IIb-IIIa Complex 1993 ·Platelets ·Michael C. Berndt, А. В. Мазуров, (unknown), Gordon F. Burns, C N Chesterman	16
5	15-hydroxyeicosatetraenoic acid synthesis from exogenous arachidonate by bronchial mucosa. 1992 ·PubMed ·(unknown), (unknown), Ian Young, (unknown), (unknown), John E. Hunt, C N Chesterman, (unknown)	7
6	Characterization of human platelet GMP-140 as a heparin-binding protein 1989 ·Biochemical and Biophysical Research Communications ·Michael P. Skinner, Dominique J. Fournier, Robert K. Andrews, Jeffrey J. Gorman, C N Chesterman, Michael C. Berndt	68
7	Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics 1989 ·British Journal of Haematology ·H. Patrick McNeil, C N Chesterman, Steven A. Krilis	130
8	Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis. 1989 ·PubMed ·Janet L. Macpherson, (unknown), Michael A. Rogers, A. I. Mallet, Robert F. Toia, Bernd W. Spur, (unknown), C N Chesterman, SA Krilis	23
9	Purification of antiphospholipid antibodies using a new affinity method 1988 ·Thrombosis Research ·H. Patrick McNeil, Steven A. Krilis, C N Chesterman	51
10	Relationship of platelet-associated immunoglobulin G and platelet protein to platelet size and density in normal individuals and patients with thrombocytopenia. 1986 ·PubMed ·Sharron L. Pfueller, C N Chesterman, (unknown), Sara Hussein, J.F. Martin	12
11	Small bowel mucosa from celiac patients generates 15-hydroxyeicosatetraenoic acid (15-HETE) after in vitro challenge with gluten. 1986 ·The Journal of Immunology ·Steven A. Krilis, Janet L. Macpherson, David J. De Carle, (unknown), (unknown), C N Chesterman	15
12	Acute postprandial lipaemia does not influence the activity of human platelets 1985 ·Thrombosis Research ·J.A. Jakubowski, N.G. Ardlie, C N Chesterman, (unknown), Francis J. Morgan	20
13	Retrospective Analysis of 158 Cases of Adult Acute Leukaemia: Factors Influencing Prognosis and Treatment Response 1982 ·Australian and New Zealand Journal of Medicine ·E. Januszewicz, Frank Firkin, C N Chesterman, O. Margaret Garson, (unknown), Michael J. Keating, D. G. Penington	6
14	The Density Distribution Of Intact Platelets Following Their Isolation From All Other Blood Constituents 1981 ·Thrombosis and Haemostasis ·(unknown), J.F. Martin, C N Chesterman, (unknown)	3
15	Detection of deep venous thrombosis by scanning of 99mtechnetium-labelled red-cell venous pool. 1979 ·BMJ ·(unknown), (unknown), Richard W. Booth, Ivo D. Vellar, Eric Gilford, C N Chesterman	34
16	The effect of sulphinpyrazone on the aggregation and release reactions of human platelets 1979 ·Thrombosis Research ·James S. Wiley, C N Chesterman, Francis J. Morgan, P.A. Castaldi	15
17	Partial amino acid sequence of human β-thromboglobulin: Structural relationship with platelet factor 4 1978 ·Thrombosis Research ·Francis J. Morgan, Geoffrey S. Begg, C N Chesterman, Duncan S. Pepper	8
18	Radioimmunoassay of Human Platelet Factor 4 1977 ·Thrombosis and Haemostasis ·C N Chesterman, (unknown), Francis J. Morgan	3
19	Controlled Trial of the Sequential Use of Streptokinase and Ancrod in the Treatment of Deep Vein Thrombosis of Lower Limb 1977 ·Thrombosis and Haemostasis ·(unknown), C N Chesterman, (unknown), (unknown), (unknown)	9
20	Measurement of fibrinogen-fibrin-related antigen in serum as aid to diagnosis of deep vein thrombosis in outpatients. 1975 ·BMJ ·David Tibbutt, C N Chesterman, M.J. Allington, Eloise Williams, (unknown)	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact